SVS Stock Overview
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Solarvest BioEnergy Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.12 |
| 52 Week Low | CA$0.01 |
| Beta | 1.54 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -77.27% |
| 33 Year Change | -72.22% |
| 5 Year Change | -86.84% |
| Change since IPO | -92.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| SVS | CA Personal Products | CA Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | 2.2% |
| 1Y | -77.3% | 5.0% | 24.3% |
Return vs Industry: SVS underperformed the Canadian Personal Products industry which returned -32.3% over the past year.
Return vs Market: SVS underperformed the Canadian Market which returned -0.8% over the past year.
Price Volatility
| SVS volatility | |
|---|---|
| SVS Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.5% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.7% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: SVS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SVS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | n/a | n/a | www.solarvest.ca |
Solarvest BioEnergy Inc. engages in the development of algal-based production systems to produce natural based green commercial products. It provides human nutrition products, including omega-3; clean energy production system that enables for continuous hydrogen production; and active ingredients for human health comprising cannabinoids in algae and bone morphogenetic protein for the treatment of repairing bone fractures. Solarvest BioEnergy Inc. has a collaborative research and development agreement with FSD Pharma Inc. to produce cannabidiol (CBD), Cannabigerol (CBG), and tetrahydrocannabinol (THC) programs.
Solarvest BioEnergy Inc. Fundamentals Summary
| SVS fundamental statistics | |
|---|---|
| Market cap | CA$1.52m |
| Earnings (TTM) | -CA$2.41m |
| Revenue (TTM) | CA$984.00 |
1,544x
P/S Ratio-0.6x
P/E RatioIs SVS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SVS income statement (TTM) | |
|---|---|
| Revenue | CA$984.00 |
| Cost of Revenue | CA$648.00 |
| Gross Profit | CA$336.00 |
| Other Expenses | CA$2.42m |
| Earnings | -CA$2.41m |
Last Reported Earnings
Jul 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.04 |
| Gross Margin | 34.15% |
| Net Profit Margin | -245,425.30% |
| Debt/Equity Ratio | -97.9% |
How did SVS perform over the long term?
See historical performance and comparison